Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-19-006088

EVP Pharmaceutical Oper & Tech gave up 919 shares (to pay taxes)

  • EVP Pharmaceutical Oper & Tech acquired 3,062 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

McKenzie Paul · EVP Pharmaceutical Oper & Tech

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2019-02-12 Exercise or conversion : show line 1 in the form +1,263 5,639.63 D
2019-02-12 Shares withheld for taxes : show line 2 in the form −380 $319.43 $121,383 5,259.63 D
2019-02-12 Exercise or conversion : show line 3 in the form +1,799 7,058.63 D
2019-02-12 Shares withheld for taxes : show line 4 in the form −539 $319.43 $172,173 6,519.63 D

Table II: Derivative

4 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-02-12 Exercise or conversion : show line 5 in the form Restricted Stock Unit −1,263 $0.00 2020-02-12 1,263 2,527 D
2019-02-12 Exercise or conversion : show line 6 in the form Restricted Stock Unit −1,799 $0.00 2021-02-12 1,799 7,671 D
2019-02-12 Other disposition : show line 7 in the form Restricted Stock Unit −1,357 $0.00 2021-02-12 1,357 6,314 D
2019-02-12 Grant or award : show line 8 in the form Restricted Stock Unit +10,960 $0.00 2022-02-12 10,960 10,960 D
Loading xslF345X03/form4.xml…